Imagine preparing for a big operation and then finding out you need to cancel your weight-loss drug regimen. That’s the case for patients taking Ozempic or Wegovy, as the American Society of Anesthesiologists has issued a warning that these trendy medications could be dangerous when combined with anesthesia during surgery. Semaglutide, the active ingredient in both drugs, belongs to a class known as GLP-1 receptor agonists, which promote weight loss by reducing appetite. However, the effects of these drugs on the body’s response to anesthesia are not yet fully understood. If you’re planning to undergo surgery, it’s crucial to talk to your healthcare provider about stopping these medications beforehand. This new safety alert raises important questions about how GLP-1 receptor agonists may interact with anesthesiology and highlights the need for further research in this area. To learn more about this warning and the potential risks associated with Ozempic and Wegovy before surgery, dive into the underlying research!
